ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 41 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $262,000 | +39.4% | 26,510 | +138.7% | 0.05% | +77.8% |
Q1 2016 | $188,000 | -61.9% | 11,108 | -49.8% | 0.03% | -49.1% |
Q4 2015 | $493,000 | +51.7% | 22,125 | -6.5% | 0.05% | +253.3% |
Q4 2013 | $325,000 | -52.6% | 23,654 | -34.9% | 0.02% | -51.6% |
Q3 2013 | $685,000 | – | 36,329 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |